发明名称 Heterocyclic compounds and methods for their use
摘要 The present invention relates to heterocyclic compounds useful for antagonizing angiotensin II Type 2 (AT2) receptor. More particularly the invention relates to piperidine compounds, compositions containing them and their use in methods of treating or preventing disorders or diseases associated with AT2 receptor function including neuropathic pain, inflammatory pain, conditions associated with neuronal hypersensitivity, impaired nerve conduction velocity, cell proliferation disorders, disorders associated with an imbalance between bone resorption and bone formation and disorders associated with aberrant nerve regeneration.
申请公布号 US9624234(B2) 申请公布日期 2017.04.18
申请号 US201314373357 申请日期 2013.01.25
申请人 NOVARTIS AG 发明人 McCarthy Thomas David;Naylor Alan
分类号 C07D491/056;C07D471/04;C07D491/048;C07D495/04;C07D211/60;C07D401/04 主分类号 C07D491/056
代理机构 代理人 Cross Sophie Binet
主权项 1. A compound of formula (I): wherein R1 is —C(═O)CH(aryl)(aryl), —C(═O)CH(aryl)(cycloalkyl), —C(═O)CH(cycloalkyl)(cycloalkyl), —C(═O)N(aryl)(aryl), —C(═O)N(aryl)(cycloalkyl) or —C(═O)N(cycloalkyl)(cycloalkyl); R2 is —CH2phenyl, —CH2CH2phenyl, —CH2CH2CH2phenyl, —OCH2phenyl, —OCH2CH2phenyl, —OCH2CH2CH2phenyl, —CH2CH═CHphenyl, —OCH2CH═CHphenyl, —OCH2C≡Cphenyl, —CH2C≡Cphenyl, —CH2OCH2phenyl, —CH2Ophenyl, —N(CH3)(2-phenypropyl), —N(CH3)(3-phenylpropyn-1-yl), —N(CH3)(phenethyl), -3-benzylmorpholine, —N(CH3)(benzyl), —N(CH3)(CH2C≡CCH3), —N(CH3)(CH2C≡CCH(CH3)2, —N(CH3) (CH2C≡C-4-fluorophenyl), —N(CH3)(CH2-4-phenyl-5-tetrazolyl), —N(CH3)(CH2-2-phenyl-1-cyclopent-1-enyl), —OCH2C≡C-4-fluorophenyl, —N(CH3)(CH2C≡CCF3), —N(CH3)(CH2C≡C—C(CH3)3, -3-phenylpiperidine, —N(CH3)(CH2C≡Cphenyl); 2-(5-phenyl)oxazolyl or 2-(5-benzyl)oxazolyl) R3b is hydrogen and R3a is —CO2H, —CH2CO2H, —C(═O)C(═O)OH, —C(═O)NH2, —CN, tetrazolyl —C(═O)NHSO2N(C1-6alkyl)2, —C(═O)NHSO2C1-6alkyl, —C(═O)NHSO2phenyl, —C(═O)NHSO2CF3—SO3H or —PO3H2; R4 is hydrogen; or a pharmaceutically acceptable salt thereof.
地址 Basel CH